TECH

Bio-Techne Corp

Jan 28 • 04:00PM ET

65.56

-2.67 -3.91 %

Healthcare • Biotechnology • USA • NASD

| Held by: VTI VOO VB RSP IVV SPY VBK FBT XLV IBB

Index	S&P 500	P/E	134.01	EPS (ttm)	0.49	Insider Own	1.20%	Shs Outstand	155.75M	Perf Week	-8.15%
Market Cap	10.22B	Forward P/E	29.70	EPS next Y	2.21	Insider Trans	-1.79%	Shs Float	153.94M	Perf Month	10.71%
Enterprise Value	10.46B	PEG	2.95	EPS next Q	0.43	Inst Own	106.57%	Short Float	6.73%	Perf Quarter	2.04%
Income	77.95M	P/S	8.40	EPS this Y	3.08%	Inst Trans	3.16%	Short Ratio	5.26	Perf Half Y	13.29%
Sales	1.22B	P/B	5.19	EPS next Y	11.54%	ROA	2.96%	Short Interest	10.36M	Perf YTD	11.48%
Book/sh	12.62	P/C	70.47	EPS next 5Y	10.06%	ROE	3.80%	52W High	79.28 -17.31%	Perf Year	-14.24%
Cash/sh	0.93	P/FCF	45.59	EPS past 3/5Y	-34.80% -20.58%	ROIC	3.32%	52W Low	46.01 42.49%	Perf 3Y	-20.33%
Dividend Est.	0.32 (0.49%)	EV/EBITDA	28.09	Sales past 3/5Y	3.33% 10.55%	Gross Margin	66.79%	Volatility	3.07% 3.52%	Perf 5Y	-26.27%
Dividend TTM	0.32 (0.49%)	EV/Sales	8.60	EPS Y/Y TTM	-48.17%	Oper. Margin	21.89%	ATR (14)	2.26	Perf 10Y	218.29%
Dividend Ex-Date	Nov 17, 2025	Quick Ratio	2.81	Sales Y/Y TTM	3.85%	Profit Margin	6.41%	RSI (14)	50.54	Recom	1.79
Dividend Gr. 3/5Y	0.00% 0.00%	Current Ratio	4.22	EPS Q/Q	17.12%	SMA20	-0.77%	Beta	1.49	Target Price	70.00
Payout	69.67%	Debt/Eq	0.20	Sales Q/Q	-1.00%	SMA50	4.63%	Rel Volume	0.92	Prev Close	68.23
Employees	3100	LT Debt/Eq	0.19	Earnings	Feb 04 BMO	SMA200	16.98%	Avg Volume	1.97M	Price	65.56
IPO	Feb 09, 1989	Option/Short	Yes / Yes	EPS/Sales Surpr.	-0.33% -1.63%	Trades		Volume	1,813,362	Change	-3.91%

Date	Action	Analyst	Rating Change	Price Target Change
Sep-03-25	Upgrade	RBC Capital Mkts	Sector Perform → Outperform	$73
Aug-21-25	Upgrade	Citigroup	Neutral → Buy	$70
Jul-22-25	Resumed	Stephens	Overweight	$65
Jul-09-25	Initiated	TD Cowen	Buy	$65
May-30-25	Initiated	Wells Fargo	Overweight	$59
Apr-09-25	Downgrade	KeyBanc Capital Markets	Overweight → Sector Weight
Mar-18-25	Initiated	Evercore ISI	Outperform	$75
Feb-19-25	Downgrade	Robert W. Baird	Outperform → Neutral	$88 → $68
May-22-24	Downgrade	Citigroup	Buy → Neutral	$85
Feb-08-24	Initiated	Scotiabank	Sector Outperform	$80
Feb-02-24	Downgrade	Stifel	Buy → Hold	$65
Dec-07-23	Initiated	UBS	Buy	$80
Aug-28-23	Initiated	William Blair	Outperform
Jan-10-23	Upgrade	Wells Fargo	Underweight → Equal Weight	$90
Dec-14-22	Initiated	Deutsche Bank	Buy	$100
Dec-12-22	Upgrade	Citigroup	Neutral → Buy	$81.25 → $100
Dec-07-22	Initiated	RBC Capital Mkts	Sector Perform	$89
Aug-25-22	Initiated	Credit Suisse	Outperform	$465
Apr-25-22	Downgrade	Wells Fargo	Equal Weight → Underweight	$370
Sep-15-21	Upgrade	KeyBanc Capital Markets	Sector Weight → Overweight	$600

Show Previous Ratings

Jan-28-26 06:30AM	Bio-Techne Launches Simple Plex Ultra-Sensitive Assays on Ella Platform to Enable Femtogram-Level Detection of Neurological Biomarkers (PR Newswire)
Jan-20-26 07:00AM	Bio-Techne to Host Conference Call on February 4, 2026, to Announce Second Quarter Fiscal 2026 Financial Results (PR Newswire)
Jan-12-26 06:49PM	Analyst Report: Bio-Techne Corporation (Morningstar Research)
Jan-09-26 08:37AM	Here's What to Expect From Bio-Techne's Next Earnings Report (Barchart)
Jan-05-26 11:05PM	3 Reasons to Avoid TECH and 1 Stock to Buy Instead (StockStory) +5.67%
07:20AM	Loading…
Jan-03-26 07:20AM	Klaviyo, Wingstop among Stephens Best Ideas for 2026 (TipRanks)
Dec-30-25 10:34PM	Research Tools & Consumables Stocks Q3 Results: Benchmarking Bio-Techne (NASDAQ:TECH) (StockStory)
Dec-23-25 07:00AM	Bio-Techne to Present at the 2026 J.P. Morgan Healthcare Conference (PR Newswire)
Dec-22-25 09:17AM	Enanta Pharmaceuticals (ENTA) Surges 5.9%: Is This an Indication of Further Gains? (Zacks)
Dec-16-25 07:40AM	Bio-Techne Stock: Is TECH Underperforming the Healthcare Sector? (Barchart)
Dec-11-25 09:36AM	Here's Why BioTechne (TECH) Traded Lower in Q3 (Insider Monkey)
06:30AM	Bio-Techne Partners with the Wyss Center Geneva to Advance Automated 3D Multiomics Technology and Accelerate Spatial Biology (PR Newswire)
Dec-09-25 06:30AM	Bio-Techne Launches the Enhanced Leo System Delivering Advanced Multiplexing and High-Throughput Protein Analysis (PR Newswire)
Dec-04-25 10:29AM	Bio-Techne Corporation (TECH): A Bull Case Theory (Insider Monkey)
Nov-25-25 07:00AM	Bio-Techne to Present at Upcoming Investor Conferences (PR Newswire)
06:30AM	Loading…
Nov-18-25 06:30AM	Bio-Techne Licenses AI-Designed NovoBody Duo Molecules from Monod Bio to Expand Recombinant Protein Portfolio (PR Newswire)
Nov-13-25 11:28PM	Bio-Techne Stock: Is Wall Street Bullish or Bearish? (Barchart)
09:01AM	Is Bio-Techne Corporation (TECH) a High-Quality Growth-Oriented Compounder Within The Healthcare Sector? (Insider Monkey)
Nov-11-25 03:55PM	Bio-Techne, Tandem Diabetes, Align Technology, DexCom, and Teleflex Shares Skyrocket, What You Need To Know (StockStory)
Nov-07-25 05:36PM	McDonald's Stock Challenged By a Tougher Economy, Analyst Says. Plus, Marriott, Snowflake, and More. (Barrons.com)
Nov-06-25 07:00AM	Bio-Techne to Present at Upcoming Investor Conferences (PR Newswire)
Nov-05-25 09:57PM	Analyst Report: Bio-Techne Corporation (Morningstar Research)
04:03PM	Bio-Techne Corp (TECH) Q1 2026 Earnings Call Highlights: Navigating Challenges with Strategic ... (GuruFocus.com)
10:52AM	TECH Stock Falls on Q1 Earnings Meet, Revenues Miss, Margins Up (Zacks)
09:30AM	Here's What Key Metrics Tell Us About Techne (TECH) Q1 Earnings (Zacks)
07:40AM	Techne (TECH) Meets Q1 Earnings Estimates (Zacks)
06:38AM	Bio-Techne (NASDAQ:TECH) Misses Q3 Revenue Estimates, Stock Drops (StockStory)
06:30AM	Bio-Techne Releases First Quarter Fiscal 2026 Results (PR Newswire)
06:30AM	BIO-TECHNE DECLARES DIVIDEND (PR Newswire)
Nov-04-25 09:01AM	AI-Powered Spatial Biology Workflow from Bio-Techne and Nucleai Enables Predictive Biomarker Discovery in Melanoma Patients (PR Newswire)
10:17PM	Loading…
Nov-03-25 10:17PM	What To Expect From Bio-Techne's (TECH) Q3 Earnings (StockStory)
07:00AM	ScaleReady Announces a G-Rex Grant has been awarded to Sonoma Biotherapeutics (PR Newswire)
Oct-31-25 03:21PM	Why Bio-Techne (TECH) Stock Is Up Today (StockStory)
Oct-30-25 07:27PM	Analyst Report: Bio-Techne Corporation (Morningstar Research)
Oct-29-25 10:00AM	Techne (TECH) Reports Next Week: What to Know Ahead of the Release (Zacks)
Oct-28-25 06:30AM	Bio-Techne Launches ProximityScope Assay on the BOND RX platform from Leica Biosystems to Advance Spatial Protein-Protein Interactions Research (PR Newswire)
Oct-23-25 06:56PM	Analyst Report: Bio-Techne Corporation (Morningstar Research)
07:54AM	Bio-Techne Q1 Earnings Preview: What's in Store for the Stock? (Zacks)
07:00AM	ScaleReady Announces multiple G-Rex Grants have been awarded to leading investigators at Children's National Hospital (PR Newswire)
Oct-16-25 12:04AM	3 Reasons to Avoid TECH and 1 Stock to Buy Instead (StockStory)
Oct-15-25 09:00AM	Saguaro Biosciences Partners with Bio-Techne to Distribute Innovative Live-Cell Imaging Reagents (Business Wire)
07:00AM	Bio-Techne to Host Conference Call on November 5, 2025, to Announce First Quarter Fiscal 2026 Financial Results (PR Newswire)
Oct-14-25 11:40AM	GMAB or TECH: Which Is the Better Value Stock Right Now? (Zacks)
08:48AM	Earnings Preview: What to Expect From Bio-Techne's Report (Barchart)
Oct-09-25 07:00AM	Bio-Techne and Oxford Nanopore Technologies Expand Agreement to Accelerate Development of Genetics Portfolio Through 2032 (PR Newswire)
Oct-08-25 08:18AM	Should You Continue to Hold Bio-Techne Stock in Your Portfolio? (Zacks)
Oct-03-25 04:16PM	S&P 500 Stocks: These 5 Lead As Index Hits Record High (Investor's Business Daily)
Sep-30-25 04:00PM	Bio-Techne (TECH) Shares Skyrocket, What You Need To Know (StockStory) +6.51% +7.71%
Sep-29-25 08:22AM	Bio-Techne Stock Climbs on Advances in Spatial Biology Solutions (Zacks)
Sep-26-25 06:30AM	Bio-Techne Advances Spatial Biology Solutions Bridging Translational Research to Clinical Applications (PR Newswire)
Sep-24-25 07:28AM	BioTechne (TECH) Fell Over the Industry's Uncertain Funding Environment (Insider Monkey)
07:15AM	Is Bio-Techne Stock Underperforming the Dow? (Barchart)
06:59AM	Bio-Techne Highlights Progress on Climate, Innovation, and Culture in 2025 Sustainability Report (PR Newswire)
Sep-19-25 09:31AM	Strength Seen in Amicus Therapeutics (FOLD): Can Its 6.4% Jump Turn into More Strength? (Zacks)
Sep-16-25 11:31PM	Research Tools & Consumables Stocks Q2 Highlights: Bio-Techne (NASDAQ:TECH) (StockStory)
Sep-15-25 09:28AM	Here's Why The Brown Capital Small Company Fund is Re-Evaluating Bio-Techne's (TECH) Long-Term Growth Profile (Insider Monkey)
Sep-10-25 03:11PM	Why Bio-Techne (TECH) Stock Is Down Today (StockStory) -5.98%
Sep-09-25 04:05PM	CONMED Corporation Adds Kim Kelderman to its Board of Directors (Business Wire)
07:00AM	ScaleReady Awards G-Rex Grants to Support Cell and Gene Therapy Manufacturing in California (PR Newswire)
Sep-02-25 02:26PM	Why Bio-Techne (TECH) Shares Are Sliding Today (StockStory)
Aug-27-25 07:00AM	Bio-Techne to Present at Upcoming Investor Conferences (PR Newswire)
Aug-22-25 03:40PM	Bio-Techne, 10x Genomics, Lumen, EPAM, and ASGN Shares Are Soaring, What You Need To Know (StockStory) +5.72%
Aug-21-25 09:36AM	CoreWeave upgraded, Instacart downgraded: Wall Street's top analyst calls (The Fly)
Aug-19-25 07:57AM	Bio-Techne Stock: Analyst Estimates & Ratings (Barchart)
Aug-14-25 07:00AM	ScaleReady Announces Award of a G-Rex Grant to the Gates Institute's Translational Sciences Laboratory (PR Newswire)
Aug-13-25 01:35AM	The 5 Most Interesting Analyst Questions From Bio-Techne's Q2 Earnings Call (StockStory)
Aug-12-25 03:17AM	TECH Q2 Deep Dive: Margin Pressures and Portfolio Shifts Amid Market Uncertainty (StockStory) +5.34%
Aug-11-25 02:56PM	Analyst Report: Bio-Techne Corporation (Morningstar Research)
Aug-06-25 01:20PM	Why Bio-Techne (TECH) Shares Are Plunging Today (StockStory) -8.73%
09:31AM	Bio-Techne (NASDAQ:TECH) Exceeds Q2 Expectations (StockStory)
09:30AM	Here's What Key Metrics Tell Us About Techne (TECH) Q4 Earnings (Zacks)
09:05AM	Bio-Techne Q4 Earnings Beat Estimates, Gross Margin Down, Stock Falls (Zacks)
07:50AM	Techne (TECH) Beats Q4 Earnings and Revenue Estimates (Zacks)
06:30AM	Bio-Techne Releases Fourth Quarter Fiscal 2025 Results (PR Newswire)
06:30AM	BIO-TECHNE DECLARES DIVIDEND (PR Newswire)
Aug-05-25 04:30PM	Bio-Techne Announces Exosome Diagnostics Divestiture (PR Newswire)
07:00AM	ScaleReady Announces a G-Rex Grant has been awarded to Sidra Medicine (PR Newswire)
Aug-04-25 11:19PM	Earnings To Watch: Bio-Techne (TECH) Reports Q2 Results Tomorrow (StockStory)
09:51AM	Bio-Techne Q4 Earnings Preview: What's in Store for the Stock? (Zacks)
Aug-01-25 08:13AM	Bio-Techne Corporation (TECH) Slid on Weakness in Research Spending (Insider Monkey)
07:46AM	Bio-Techne Corporation (TECH) Slid on Rise in Investors' Concerns (Insider Monkey)
Jul-31-25 07:00AM	ScaleReady announces multiple G-Rex® Grants have been awarded to investigators at University of Minnesota's Center for Genome Engineering (PR Newswire) -5.16%
Jul-30-25 12:03AM	3 Reasons to Avoid TECH and 1 Stock to Buy Instead (StockStory)
Jul-28-25 02:07AM	Bio-Techne Corporation (TECH) Gets Initiated With a New Buy Rating at TD Cowen (Insider Monkey)
Jul-24-25 04:07PM	Bio-Techne Corporation (TECH): A Bull Case Theory (Insider Monkey) +5.71%
Jul-22-25 02:05PM	Bio-Techne (TECH) Stock Is Up, What You Need To Know (StockStory) +5.67%
Jul-18-25 01:03AM	Bio-Technes Quarterly Earnings Preview: What You Need to Know (Barchart)
Jul-17-25 07:00AM	Bio-Techne to Host Conference Call on August 6, 2025, to Announce Fourth Quarter and Fiscal 2025 Financial Results (PR Newswire)
Jul-16-25 11:40AM	INCY or TECH: Which Is the Better Value Stock Right Now? (Zacks)
Jul-15-25 10:09AM	Here's Headwaters Capital Management's Investment Thesis for Bio-Techne (TECH) (Insider Monkey)
09:03AM	Spear Bio Announces Strategic Partnership with Bio-Techne to Accelerate the Deployment of Its Next-Generation Immunoassay Technology (Business Wire)
07:00AM	Bio-Techne and Spear Bio Announce Strategic Partnership to Advance Therapeutic Development with Ultrasensitive Biomarker Detection (PR Newswire)
Jul-14-25 07:00AM	Bio-Techne's Simple Western Technology Utilized in Recent FDA Approval of ZEVASKYN Cell-Based Gene Therapy (PR Newswire)
Jul-09-25 01:33AM	5 Revealing Analyst Questions From Bio-Techne's Q1 Earnings Call (StockStory)
Jun-30-25 08:49AM	Bio-Techne's New USP Deal on mAb and Gene Therapy May Boost Its Stock (Zacks)
Jun-25-25 04:46PM	Bio-Techne, USP Partner to Enhance Monoclonal Antibody, Gene Therapy Development (Insider Monkey)
08:44AM	Is Bio-Techne Stock Underperforming the Nasdaq? (Barchart)
Jun-24-25 07:00AM	Bio-Techne and USP Announce Collaboration to Accelerate Monoclonal Antibody and Gene Therapy Product Development (PR Newswire)
Jun-10-25 01:15PM	TECH Q1 Earnings Call: Management Highlights Market Uncertainties and Strategic Mitigation Efforts (StockStory)
07:00AM	ScaleReady Announces a G-Rex Grant has been awarded to Immuneel Therapeutics (PR Newswire)

Bio-Techne Corp. is a global life sciences company providing innovative tools and bioactive reagents for research and clinical diagnostic communities. Its products assist scientific investigations into biological processes and the nature and progress of specific diseases. It operates through the Protein Sciences, and Diagnostics and Spatial Biology segments. The Protein Sciences segment develops and manufactures purified proteins, and reagent solutions. The Diagnostics and Spatial Biology segment develops and manufactures diagnostic products. The company was founded in 1976 and is headquartered in Minneapolis, MN.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Hippel James	CFO	Nov 03 '25	Option Exercise	0.00	24,704	0	154,587	Nov 05 04:46 PM
Geist William	PRESIDENT, PROTEIN SCIENCES	Nov 03 '25	Option Exercise	0.00	9,911	0	25,023	Nov 05 04:46 PM
Nusse Roeland	Director	Aug 25 '25	Option Exercise	21.84	17,040	372,154	61,599	Aug 27 04:10 PM
Nusse Roeland	Director	Aug 25 '25	Sale	56.36	17,040	960,388	44,559	Aug 27 04:10 PM
BAUMGARTNER ROBERT V	Director	Aug 25 '25	Option Exercise	21.84	17,040	372,154	61,903	Aug 27 04:09 PM
BAUMGARTNER ROBERT V	Director	Aug 25 '25	Sale	56.21	17,040	957,818	44,863	Aug 27 04:09 PM
ROELAND NUSSE	Director	Aug 25 '25	Proposed Sale	56.36	17,040	960,388		Aug 25 04:05 PM
ROBERT V. BAUMGARTNER4731 BONI	Director	Aug 25 '25	Proposed Sale	56.21	17,040	957,849		Aug 25 04:04 PM
Hippel James	CFO	Aug 15 '25	Option Exercise	0.00	4,010	0	131,809	Aug 19 05:38 PM
Herr Amy E.	Director	Aug 15 '25	Option Exercise	0.00	279	0	2,255	Aug 19 05:29 PM
Kelderman Kim	Chief Executive Officer	Aug 15 '25	Option Exercise	0.00	8,543	0	55,273	Aug 19 05:28 PM
Bohnen Shane	SVP - General Counsel	Aug 15 '25	Option Exercise	0.00	1,718	0	4,912	Aug 19 05:28 PM
McManus Matthew	President - Diag & Spatial Bio	Aug 15 '25	Option Exercise	0.00	2,637	0	5,615	Aug 19 05:28 PM
Geist William	PRESIDENT, PROTEIN SCIENCES	Aug 15 '25	Option Exercise	0.00	2,623	0	15,915	Aug 19 05:27 PM
HIGGINS JOHN L	Director	Aug 07 '25	Option Exercise	21.84	5,040	110,074	65,236	Aug 11 07:06 PM
Hippel James	CFO	Jul 29 '25	Option Exercise	44.33	168,620	7,474,925	275,230	Jul 31 04:28 PM
Kelderman Kim	Chief Executive Officer	Jul 22 '25	Option Exercise	44.33	48,176	2,135,642	90,379	Jul 24 04:26 PM
Kelderman Kim	Chief Executive Officer	Jul 15 '25	Option Exercise	44.33	36,132	1,601,732	75,136	Jul 17 05:04 PM
Herr Amy E.	Director	Jun 09 '25	Option Exercise	44.33	1,280	56,742	3,256	Jun 11 04:20 PM
Herr Amy E.	Director	Jun 09 '25	Sale	49.77	1,280	63,705	1,976	Jun 11 04:20 PM
JOSHUA MOLHO	Officer	Jun 09 '25	Proposed Sale	49.77	1,280	63,705		Jun 09 04:19 PM
HIGGINS JOHN L	Director	May 01 '25	Option Exercise	21.84	12,000	262,080	60,196	May 05 04:18 PM
Bohnen Shane	SVP - General Counsel	Apr 03 '25	Option Exercise	0.00	2,260	0	3,941	Apr 07 04:25 PM
Herr Amy E.	Director	Feb 14 '25	Option Exercise	44.33	1,976	87,596	3,836	Feb 18 04:49 PM
Herr Amy E.	Director	Feb 14 '25	Sale	65.96	1,860	122,691	1,976	Feb 18 04:49 PM
JOSHUA MOLHO	Domestic Partner of Director	Feb 14 '25	Proposed Sale	65.96	1,860	122,691		Feb 14 04:08 PM
McManus Matthew	President - DGS	Feb 01 '25	Option Exercise	0.00	4,620	0	4,620	Feb 04 05:31 PM
Geist William	PRESIDENT, PROTEIN SCIENCES	Feb 01 '25	Option Exercise	0.00	3,320	0	14,401	Feb 04 05:27 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

TECH

Bio-Techne Corp

Upgrade your FINVIZ experience